| Cellular component | cytoskeletal part - GO:0044430; membrane - GO:0016020; nuclear part - GO:0044428; microtubule organizing center - GO:0005815; organelle - GO:0043226; intracellular part - GO:0044424; cellular_component - GO:0005575; intracellular non-membrane-bounded organelle - GO:0043232; nucleoplasm part - GO:0044451; nucleolus - GO:0005730; protein complex - GO:0043234; mediator complex - GO:0016592; ubiquitin ligase complex - GO:0000151; centrosome - GO:0005813; intracellular membrane-bounded organelle - GO:0043231; cell part - GO:0044464; macromolecular complex - GO:0032991; non-membrane-bounded organelle - GO:0043228; membrane-bounded organelle - GO:0043227; nucleoplasm - GO:0005654; organelle part - GO:0044422; intracellular organelle - GO:0043229; intracellular organelle part - GO:0044446; nucleus - GO:0005634; |
| Molecular function | RNA polymerase II distal enhancer sequence-specific DNA binding - GO:0000980; receptor binding - GO:0005102; regulatory region dna binding - GO:0000975; binding - GO:0005488; receptor activity - GO:0004872; protein binding transcription factor activity - GO:0000988; beta-catenin binding - GO:0008013; molecular transducer activity - GO:0060089; sequence-specific dna binding - GO:0043565; rna polymerase ii transcription cofactor activity - GO:0001104; rna polymerase ii distal enhancer sequence-specific dna binding - GO:0000980; ubiquitin protein ligase activity - GO:0061630; protein binding - GO:0005515; transcription regulatory region sequence-specific dna binding - GO:0000976; transcription cofactor activity - GO:0003712; enhancer binding - GO:0035326; protein c-terminus binding - GO:0008022; protein C-terminus binding - GO:0008022; enhancer sequence-specific dna binding - GO:0001158; heterocyclic compound binding - GO:1901363; protein domain specific binding - GO:0019904; rna polymerase ii transcription factor binding transcription factor activity involved in positive regulation of transcription - GO:0001190; transcription factor binding transcription factor activity - GO:0000989; vitamin D receptor binding - GO:0042809; dna binding - GO:0003677; transcription regulatory region dna binding - GO:0044212; nuclear hormone receptor binding - GO:0035257; molecular_function - GO:0003674; chromatin binding - GO:0003682; rna polymerase ii regulatory region dna binding - GO:0001012; thyroid hormone receptor binding - GO:0046966; nucleic acid binding - GO:0003676; regulatory region nucleic acid binding - GO:0001067; transcription factor binding - GO:0008134; rna polymerase ii transcription factor binding transcription factor activity - GO:0001076; hormone receptor binding - GO:0051427; ligand-dependent nuclear receptor transcription coactivator activity - GO:0030374; organic cyclic compound binding - GO:0097159; vitamin d receptor binding - GO:0042809; transcription coactivator activity - GO:0003713; rna polymerase ii regulatory region sequence-specific dna binding - GO:0000977; macromolecular complex binding - GO:0044877; |
| Biological process | stem cell population maintenance - GO:0019827; negative regulation of response to stimulus - GO:0048585; regulation of rna metabolic process - GO:0051252; glial cell development - GO:0021782; positive regulation of transcription from RNA polymerase II promoter - GO:0045944; macromolecule metabolic process - GO:0043170; regulation of developmental process - GO:0050793; regulation of signaling - GO:0023051; positive regulation of transcription; DNA-templated - GO:0045893; cell development - GO:0048468; positive regulation of macromolecule metabolic process - GO:0010604; Wnt signaling pathway; planar cell polarity pathway - GO:0060071; single-organism process - GO:0044699; nitrogen compound metabolic process - GO:0006807; rna biosynthetic process - GO:0032774; transcription initiation from rna polymerase ii promoter - GO:0006367; regulation of nucleic acid-templated transcription - GO:1903506; primary metabolic process - GO:0044238; androgen receptor signaling pathway - GO:0030521; regulation of cell communication - GO:0010646; positive regulation of rna biosynthetic process - GO:1902680; signal transduction - GO:0007165; embryonic neurocranium morphogenesis - GO:0048702; intracellular receptor signaling pathway - GO:0030522; positive regulation of biological process - GO:0048518; spinal cord development - GO:0021510; tube closure - GO:0060606; negative regulation of wnt signaling pathway - GO:0030178; multicellular organismal process - GO:0032501; regulation of cellular process - GO:0050794; tube formation - GO:0035148; regulation of macromolecule biosynthetic process - GO:0010556; cellular metabolic process - GO:0044237; anatomical structure development - GO:0048856; regulation of organ morphogenesis - GO:2000027; macromolecule biosynthetic process - GO:0009059; positive regulation of transcription; dna-templated - GO:0045893; positive regulation of gene expression - GO:0010628; regulation of metabolic process - GO:0019222; regulation of multicellular organismal development - GO:2000026; heart development - GO:0007507; axis elongation involved in somitogenesis - GO:0090245; regulation of response to stimulus - GO:0048583; positive regulation of cellular process - GO:0048522; negative regulation of cellular process - GO:0048523; stem cell maintenance - GO:0019827; growth - GO:0040007; regulation of macromolecule metabolic process - GO:0060255; nucleic acid metabolic process - GO:0090304; metabolic process - GO:0008152; aromatic compound biosynthetic process - GO:0019438; regulation of transcription from rna polymerase ii promoter - GO:0006357; regulation of cell differentiation - GO:0045595; organ development - GO:0048513; canonical wnt signaling pathway - GO:0060070; regulation of nitrogen compound metabolic process - GO:0051171; regulation of cellular biosynthetic process - GO:0031326; wnt signaling pathway - GO:0016055; oligodendrocyte development - GO:0014003; negative regulation of developmental process - GO:0051093; organic cyclic compound biosynthetic process - GO:1901362; canonical Wnt signaling pathway - GO:0060070; regulation of gene expression - GO:0010468; positive regulation of biosynthetic process - GO:0009891; post-anal tail morphogenesis - GO:0036342; nucleobase-containing compound metabolic process - GO:0006139; heterocycle biosynthetic process - GO:0018130; regulation of wnt signaling pathway - GO:0030111; axis elongation - GO:0003401; regulation of primary metabolic process - GO:0080090; cellular developmental process - GO:0048869; regulation of biological process - GO:0050789; developmental growth - GO:0048589; heterocycle metabolic process - GO:0046483; gene expression - GO:0010467; rna metabolic process - GO:0016070; positive regulation of nucleobase-containing compound metabolic process - GO:0045935; organic cyclic compound metabolic process - GO:1901360; biological regulation - GO:0065007; cellular biosynthetic process - GO:0044249; regulation of multicellular organismal process - GO:0051239; negative regulation of signal transduction - GO:0009968; regulation of cellular macromolecule biosynthetic process - GO:2000112; regulation of transcription from RNA polymerase II promoter - GO:0006357; transcription initiation from RNA polymerase II promoter - GO:0006367; embryonic brain development - GO:1990403; regulation of signal transduction - GO:0009966; regulation of anatomical structure morphogenesis - GO:0022603; endoderm development - GO:0007492; schwann cell development - GO:0014044; developmental process - GO:0032502; nucleobase-containing compound biosynthetic process - GO:0034654; cellular macromolecule metabolic process - GO:0044260; single-organism cellular process - GO:0044763; cellular nitrogen compound metabolic process - GO:0034641; non-canonical wnt signaling pathway - GO:0035567; positive regulation of cellular metabolic process - GO:0031325; negative regulation of cell differentiation - GO:0045596; protein ubiquitination - GO:0016567; positive regulation of nitrogen compound metabolic process - GO:0051173; positive regulation of macromolecule biosynthetic process - GO:0010557; cellular process - GO:0009987; negative regulation of cell communication - GO:0010648; regulation of establishment of planar polarity - GO:0090175; positive regulation of cellular biosynthetic process - GO:0031328; biological_process - GO:0008150; intracellular steroid hormone receptor signaling pathway - GO:0030518; single-organism developmental process - GO:0044767; anatomical structure formation involved in morphogenesis - GO:0048646; wnt signaling pathway; planar cell polarity pathway - GO:0060071; negative regulation of biological process - GO:0048519; cellular aromatic compound metabolic process - GO:0006725; positive regulation of rna metabolic process - GO:0051254; organic substance biosynthetic process - GO:1901576; regulation of cellular metabolic process - GO:0031323; regulation of rna biosynthetic process - GO:2001141; Schwann cell development - GO:0014044; regulation of transcription; dna-templated - GO:0006355; positive regulation of transcription from rna polymerase ii promoter - GO:0045944; negative regulation of signaling - GO:0023057; biosynthetic process - GO:0009058; cell surface receptor signaling pathway - GO:0007166; positive regulation of nucleic acid-templated transcription - GO:1903508; organic substance metabolic process - GO:0071704; regulation of biosynthetic process - GO:0009889; cellular nitrogen compound biosynthetic process - GO:0044271; developmental growth involved in morphogenesis - GO:0060560; single-multicellular organism process - GO:0044707; regulation of nucleobase-containing compound metabolic process - GO:0019219; neural tube closure - GO:0001843; dna-templated transcription; initiation - GO:0006352; positive regulation of metabolic process - GO:0009893; |
|---|